Pharmacyte Biotech Inc has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on December 08, 2003 with the ratio of 3-for-1, meaning that for 1 share of PMCB owned pre-split, shareholders then owned 3 shares. The most recent stock split took place on July 12, 2021 on a 1-for-1500 basis.
These actions have increased PMCB stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Pharmacyte Biotech Inc's total market capitalization.
For more detailed information of Pharmacyte Biotech Inc's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Pharmacyte Biotech Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when PMCB stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Pharmacyte Biotech Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
